Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/24/20 → 3/14/22 |
Funding
- AbbVie Incorporated: $33,824.00
A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke
- Hatton, Kevin (PI)
- Lee, Jessica (CoI)
- Swafford, Kara (CoI)